Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Research from ACR Convergence 2025 highlighted GLP-1 receptor agonists as showing particular promise in psoriatic arthritis management, where the dual burden of skin and joint disease creates challenges for conventional therapies
When combined with intensive behavioral therapy (STEP 3), results were even stronger participants achieved approximately 16% weight loss at 68 weeks with the added benefit of structured dietary and exercise guidance (Wadden et al., 2021)
Shawn Salley/Shutterstock
Key Research Characteristics Synthetic peptide research compound Lyophilized powder for reconstitution 10mg vial format Research use only
GLP drugs are synthetic replacement for the natural satiety hormone, so temporarily alters the same signalling mechanism bariatric surgery works on
Many insurance companies are familiar with it and have it on their list of covered medications
